Molina Healthcare, Inc. (NYSE:MOH - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for Molina Healthcare in a report issued on Monday, June 9th. Cantor Fitzgerald analyst S. James anticipates that the company will earn $28.03 per share for the year. The consensus estimate for Molina Healthcare's current full-year earnings is $24.40 per share.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, beating analysts' consensus estimates of $5.96 by $0.12. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The firm had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. During the same quarter last year, the business posted $5.73 earnings per share. The company's quarterly revenue was up 12.2% on a year-over-year basis.
A number of other research analysts have also issued reports on the stock. Truist Financial raised their price objective on shares of Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a report on Friday, April 11th. Wells Fargo & Company upgraded shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $295.00 to $372.00 in a report on Wednesday, March 5th. Morgan Stanley started coverage on shares of Molina Healthcare in a research note on Monday. They issued an "overweight" rating and a $364.00 price objective on the stock. Mizuho raised their target price on Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Finally, Baird R W downgraded Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Nine investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, Molina Healthcare currently has an average rating of "Hold" and an average target price of $364.21.
Check Out Our Latest Stock Report on Molina Healthcare
Molina Healthcare Price Performance
MOH traded down $1.46 on Tuesday, reaching $293.16. The stock had a trading volume of 542,774 shares, compared to its average volume of 725,943. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $15.89 billion, a price-to-earnings ratio of 14.35, a price-to-earnings-growth ratio of 1.06 and a beta of 0.57. Molina Healthcare has a fifty-two week low of $262.32 and a fifty-two week high of $365.23. The firm has a 50-day moving average of $317.68 and a 200-day moving average of $307.22.
Insiders Place Their Bets
In related news, CEO Joseph M. Zubretsky sold 87,500 shares of Molina Healthcare stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the completion of the sale, the chief executive officer now owns 257,715 shares of the company's stock, valued at approximately $82,484,262.90. This trade represents a 25.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Richard M. Schapiro sold 669 shares of the company's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the transaction, the director now owns 11,244 shares in the company, valued at approximately $3,603,702. The trade was a 5.62% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.26% of the company's stock.
Hedge Funds Weigh In On Molina Healthcare
Several large investors have recently added to or reduced their stakes in MOH. Price T Rowe Associates Inc. MD raised its stake in shares of Molina Healthcare by 46.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company's stock worth $1,264,214,000 after purchasing an additional 1,216,903 shares during the last quarter. GAMMA Investing LLC grew its holdings in Molina Healthcare by 74,593.7% during the first quarter. GAMMA Investing LLC now owns 667,015 shares of the company's stock worth $219,708,000 after buying an additional 666,122 shares in the last quarter. Norges Bank purchased a new stake in Molina Healthcare in the 4th quarter valued at $134,675,000. FMR LLC lifted its stake in Molina Healthcare by 31.1% during the 4th quarter. FMR LLC now owns 1,801,113 shares of the company's stock valued at $524,214,000 after acquiring an additional 427,276 shares in the last quarter. Finally, Voloridge Investment Management LLC boosted its holdings in Molina Healthcare by 1,641.3% during the 4th quarter. Voloridge Investment Management LLC now owns 409,807 shares of the company's stock worth $119,274,000 after acquiring an additional 386,273 shares during the last quarter. Institutional investors own 98.50% of the company's stock.
Molina Healthcare Company Profile
(
Get Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
See Also

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.